tirzepatide cost vs semaglutide
Why Semaglutide Is Already Obsolete
Semaglutide is already obsolete because its typical annual out-of-pocket cost tops $1,600, a price many patients can’t sustain. The drug’s high price, limited coverage, and emerging competitor tirzepatide are shifting clinician and payer preferences. Medical Disclaimer: This article is for informational purposes only and does not constitute